DWA
OSIR

Dorsey Wright & Associates’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Dorsey Wright & Associates’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-597
Closed -$11K – 362
2019
Q1 		$11K Sell
597
-597
-50% -$9.68K ﹤0.01% 171
2018
Q4 		$16K Buy
+1,194
New +$13.3K ﹤0.01% 181

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Dorsey Wright & Associates's OSIR Position: Q2 2019 in Review

Dorsey Wright & Associates sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 597 shares — an estimated $11K sold.

Dorsey Wright & Associates first reported a position in OSIR in Q4 2018 and held it in 2 quarters. The position peaked at $16K in Q4 2018. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Dorsey Wright & Associates reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Dorsey Wright & Associates sold 597 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $11K.
  • Dorsey Wright & Associates first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2018 and held it in 2 quarters.
  • Dorsey Wright & Associates's Osiris Therapeutics, Inc. Common Stock position peaked at $16K in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Dorsey Wright & Associates's 13F filing for Q2 2019, filed 2 Jul 2019.